Researchers at the MRC Laboratory of Molecular Biology (LMB) have discovered a tiny RNA molecule that could explain how life on Earth began.
🔬 Read more: biosciencetoday.co.uk/chemic…#LifeSciences#Biology
Methylene blue is the best agent for gastric #chromoendoscopy. It gets absorbed by the intestinal metaplastic cells and cannot be washed out, unlike in the colon.
Because it also gets absorbed by normal intestinal cells, patients will pee blue that day💧
#medtwitter#gitwitter
Could you see yourself pitching in next year's @Entirl#StudentEntrepreneurAwards?
We're already looking ahead to the next generation of student entrepreneurs ready to take their ideas from concept to commercial reality in 2027
🔗 Learn more:
enterprise-ireland.com/stude…
#JobOpening for a Laboratory Technician in the @BiologyatYork Teaching Laboratories providing essential support (inc. autoclaving, glasswash stock checks) underpinning all laboratory teaching activities. Apply by 22/06/2026 jobs.york.ac.uk/vacancy/labo…
Podcast: PET tracers' role in precision medicine paradigms for neurodegenerative diseases
Swiss biotech AC Immune discusses its PET tracer's potential in realising precision medicine approaches to neurodegenerative diseases.
medicaldevice-network.com/fe…
We asked 111 physicians on G-Med:
Should sexual orientation be part of routine patient history taking?
Here’s what they said:
📊 47% ask only when clinically relevant
📊 20% usually don’t need to know
📊 19% prefer patients disclose voluntarily
📊 9% routinely ask as part of the anamnesis
📊 5% would rather not know
The responses suggest there is no one-size-fits-all approach. Many physicians emphasized that context, trust, and clinical relevance should guide these conversations.
How do you approach this in your practice?
#PrideMonth
ALT We asked 111 physicians on G-Med:
Should sexual orientation be part of routine patient history taking?
Here’s what they said:
📊 47% ask only when clinically relevant
📊 20% usually don’t need to know
📊 19% prefer patients disclose voluntarily
📊 9% routinely ask as part of the anamnesis
📊 5% would rather not know
The responses suggest there is no one-size-fits-all approach. Many physicians emphasized that context, trust, and clinical relevance should guide these conversations.
How do you approach this in your practice? Pride month
Manual chart review is slow, labor-intensive, and hard to scale. In this clip, I talk about a study where GPT-4 matched or outperformed rule-based phenotyping for Crohn’s disease subtyping.
Full episode: youtube.com/live/Bzx3NRfxVbM…#medicalAI#healthcareAI
Case of the Day: 73F w/ fever, rigors, jaundice, & a hepatic lesion on CT. What does the imaging reveal, & how would you approach the diagnosis?
Sign in w/ your NHS/academic email to view & add your comments.
sbee.link/hbecry8t9k#medtwitter#foamed#radiology@AmineKorchiMD
Our highly professional Validation Engineers have exceptional experience in authoring & delivering full suite of validation life-cycle documents: Planning, Specification, Design, Testing & Release > independentsolutions.ie#Pharma#BioTech#MedTech#Pharmaceuticals
Before the next issue of EBR, take another look at @Levicept's article on novel biologics for #osteoarthritis: a new MoA to tackle pain and modify disease
Read here: rebrand.ly/b55e7d
The primary is the source of first progression in >50% of cases of #lungcancer patients, and TRACERx showed us that in 32% of NSCLC the primary polyclonally seeds metastases. In our @IASLC consensus, now in JTO shorturl.at/GzAe2, makes the case for eradicating it with #radiotherapy. The EGFRm phase III data are the most compelling OS 34.4 vs 26.2 months with TKI RT. There are still unresolved questions in the non-AGA population. We are opening the phase III PRIME-LUNG trial shorturl.at/26apO@TROGfightcancer@TOGAANZ to answer this question! #radonc